| Literature DB >> 20695017 |
Hitoshi Osaka1, Haruka Hamanoue, Ryoko Yamamoto, Atsuo Nezu, Megumi Sasaki, Hirotomo Saitsu, Kenji Kurosawa, Hiroko Shimbo, Naomichi Matsumoto, Ken Inoue.
Abstract
Mutations in the gap junction protein gamma-2 gene, GJC2, cause a central hypomyelinating disorder; Pelizaeus-Merzbacher-like disease (PMLD; MIM311601). Using a homozygosity mapping and positional candidate gene approach, we identified a homozygous mutation (c.-167A>G) within the GJC2 promoter at a potent SOX10 binding site in a patient with mild PMLD. Functionally, this mutation completely abolished the SOX10 binding and attenuated GJC2 promoter activity. These findings suggest not only that the SOX10-to-GJC2 transcriptional dysregulation is a cause of PMLD, but also that GJC2 may be in part responsible for the central hypomyelination caused by SOX10 mutations.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20695017 DOI: 10.1002/ana.22022
Source DB: PubMed Journal: Ann Neurol ISSN: 0364-5134 Impact factor: 10.422